BCMU
GILD icon

BlueCrest Capital Management (UK)’s Gilead Sciences GILD Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$518K Buy
+4,866
New +$476K 0.02% 411
2014
Q2 		– Sell
-2,930
Closed -$208K – 631
2014
Q1 		$208K Buy
+2,930
New +$230K 0.01% 459

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlueCrest Capital Management (UK)'s GILD Position: Q3 2014 in Review

BlueCrest Capital Management (UK) opened a new position in Gilead Sciences (GILD) in Q3 2014: 4,866 shares worth $518K. The stake represents 0.02% of the portfolio and ranks #411 among its holdings. This is a return to the name: BlueCrest Capital Management (UK) previously reported a position in GILD as recently as Q1 2014.

BlueCrest Capital Management (UK) first reported a position in GILD in Q1 2014 and has held it in 2 quarters since. 1,326 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

  • BlueCrest Capital Management (UK) held 4,866 shares of Gilead Sciences worth $518K as of Q3 2014.
  • Gilead Sciences was a new BlueCrest Capital Management (UK) position in Q3 2014.
  • Gilead Sciences made up 0.02% of BlueCrest Capital Management (UK)'s portfolio in Q3 2014, its #411 holding.
  • BlueCrest Capital Management (UK) first reported a position in Gilead Sciences in Q1 2014 and has held it in 2 quarters since.
  • 1,326 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q3 2014, filed 13 Nov 2014.